Efrat Eliyahu, Michael G Katz, Adam Vincek, Lina Freage-Kahn, Shana Ravvin, Smadar Tal, Henry Grage, Nataly Shtraizent, Tuvia Barak, Bezalel Arkush. Effects of Hormone Replacement Therapy on Women's Lung Health and Disease.Pulmonary therapy. 2023, 9 (4): 461-477
Michael S Schechter, Natalia Sabater-Anaya, Gerry Oster, Derek Weycker, Hongsheng Wu, Emilio Arteaga-Solis, Sukirti Bagal, Lisa J McGarry, Kate Van Brunt, Jessica Morlando Geiger. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Resource Utilization and Associated Costs Among People With Cystic Fibrosis in the US: A Retrospective Claims Analysis.Pulmonary therapy. 2023, 9 (4): 479-498
Luis Morales-Quinteros, Raffaele Scala, João Manoel Silva, Antonio Leidi, Alexandre Leszek, Rodrigo Vazquez-Guillamet, Sergi Pascual, Ary Serpa-Neto, Antonio Artigas, Marcus J Schultz. Associations of Awake Prone Positioning-Induced Changes in Physiology with Intubation: An International Prospective Observational Study in Patients with Acute Hypoxemic Respiratory Failure Related to COVID-19.Pulmonary therapy. 2023, 9 (4): 499-510
Junichi Omura, Yogeshwar Makanji, Nobuhiro Tanabe, Dae Young Yu, Jin Yu Tan, Sooyeol Lim, Mahsa H Kouhkamari, Jeremy Casorso, David Bin-Chia Wu, Paul Bloomfield. Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study.Pulmonary therapy. 2023, 9 (4): 511-526
Andi C Hudler, Isaías Raymundo Ramírez Díaz, Sunita Sharma, Fernando Holguin. Gaps and Future Directions in Clinical Research on Obesity-Related Asthma.Pulmonary therapy. 2023, 9 (3): 309-327
Andrea S Melani, Sara Croce, Lucia Cassai, Giusy Montuori, Gaia Fabbri, Maddalena Messina, Magda Viani, Elena Bargagli. Systemic Corticosteroids for Treating Respiratory Diseases: Less Is Better, but… When and How Is It Possible in Real Life?Pulmonary therapy. 2023, 9 (3): 329-344
Paul D Terry, Rajiv Dhand. The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD.Pulmonary therapy. 2023, 9 (3): 345-357
Nathaniel Keidan, Avinash Aujayeb. Small Cell Lung Cancer and Pleural Effusion: An Analysis from a District General Hospital.Pulmonary therapy. 2023, 9 (3): 359-365
Sy Duong-Quy, Duc Huynh-Truong-Anh, Thanh Nguyen-Thi-Kim, Tien Nguyen-Quang, Thuy Tran-Ngoc-Anh, Nam Nguyen-Van-Hoai, Mai Do-Thi-Thu, Thanh Nguyen-Chi, Toi Nguyen-Van, Tram Tang-Thi-Thao, Anh Nguyen-Tuan, Quan Nguyen-Hoang, Phung Hoang-Phi-Tuyet, Giap Vu-Van, Hieu Nguyen-Lan, Chuong Nguyen-Hong, Sy Dinh-Ngoc, Dung Truong-Viet, Vinh Nguyen-Nhu, Thai Nguyen-Duy. Predictive Factors of Mortality in Patients with Severe COVID-19 Treated in the Intensive Care Unit: A Single-Center Study in Vietnam.Pulmonary therapy. 2023, 9 (3): 377-394
Richard N van Zyl-Smit, Huib A M Kerstjens, Jorge Maspero, Ana-Maria Tanase, David Lawrence, Karen Mezzi, Peter D'Andrea, Kenneth R Chapman. Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses.Pulmonary therapy. 2023, 9 (3): 395-409
Bing Zhou, Lei Cheng, Jing Pan, Huizhong Wang, Yongde Jin, Changqing Zhao, Peng Lin, Guolin Tan, Hongyan Fang, Hua Zhang, Huifang Zhou, Yaowu Dong, Hans Christian Kuhl, Rajesh Kumar Ramalingam, Duc Tung Nguyen. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.Pulmonary therapy. 2023, 9 (3): 411-427
Holger Woehrle, Paul Mastoridis, David Stempel, Leanne Kaye, Vy Vuong, Karen Mezzi. Medication Adherence and Asthma Control with Once-Daily Indacaterol/Glycopyrronium/Mometasone Furoate Breezhaler Digital Companion: 90-Day Analysis from Germany.Pulmonary therapy. 2023, 9 (3): 429-434